Icon Legend

This session is not in your schedule.

This session is in your schedule. Click again to remove it.

Session Icons

Live Streamed

On Demand

289 Views

Session: Novel Strategies to Diagnose, Monitor, Treat and Prevent Hepatitis B and Hepatitis D

420 - Hepatitis D Chronic Infection: Current and Future Treatments

Tuesday, October 21, 2025

2:35 PM - 3:00 PM US ET

Location: B308-B309

Speaker(s)

Tarik Asselah, MD PhD (he/him/his)

Professor of Hepatology, Head of Viral Hepatitis
Université de Paris-Cité. Hôpital Beaujon, Paris, France., France

Slides

Disclosure(s):

Tarik Asselah, MD PhD: AbbVie: Advisor/Consultant, Board Member, Grant/Research Support, Honoraria; Aligos Therapeutics: Advisor/Consultant, Board Member, Grant/Research Support, Honoraria; Antios Therapeutics: Advisor/Consultant, Honoraria; Bluejay: Advisor/Consultant, Board Member, Grant/Research Support, Honoraria; Gilead Sciences: Advisor/Consultant, Board Member, Grant/Research Support, Honoraria; GSK: Advisor/Consultant, Board Member, Grant/Research Support, Honoraria; Vir Biotechnology: Advisor/Consultant, Board Member, Grant/Research Support, Honoraria